BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koizumi W, Saigenji K, Nakamaru N, Okayasu I, Kurihara M. Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor. Oncology. 1999;56:215-222. [PMID: 10202277 DOI: 10.1159/000011968] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Jang JS, Lee WS, Lee JS, Kim HW, Ko GH, Ha WS. The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer. J Korean Med Sci 2007;22 Suppl:S109-14. [PMID: 17923735 DOI: 10.3346/jkms.2007.22.S.S109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Cuq P, Rouquet C, Evrard A, Ciccolini J, Vian L, Cano JP. Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase. Br J Cancer 2001;84:1677-80. [PMID: 11401323 DOI: 10.1054/bjoc.2001.1833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
3 Miyazaki K, Shibahara T, Sato D, Uchida K, Suzuki H, Matsui H, Yanaka A, Nakahara A, Matsuzaki Y. Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines. J Gastroenterol 2006;41:140-50. [DOI: 10.1007/s00535-005-1733-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
4 Saif MW, Black G, Roy S, Bell D, Russo S, Eloubeidi MA, Steg A, Johnson MR, Zelterman D, Diasio RB. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase. Cancer J 2007;13:247-56. [PMID: 17762760 DOI: 10.1097/PPO.0b013e31813c12b8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
5 Yamashita T, Kato K, Long NK, Makita H, Yonemoto K, Iida K, Tamaoki N, Hatakeyama D, Shibata T. Effects of smoking and alcohol consumption on 5-fluorouracil-related metabolic enzymes in oral squamous cell carcinoma. Mol Clin Oncol 2014;2:429-34. [PMID: 24772313 DOI: 10.3892/mco.2014.267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
6 Toi M, Bando H, Horiguchi S, Takada M, Kataoka A, Ueno T, Saji S, Muta M, Funata N, Ohno S. Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer. Br J Cancer 2004;90:2338-43. [PMID: 15150550 DOI: 10.1038/sj.bjc.6601845] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
7 Yu XQ. Preoperative administration of xeloda on the angiogenesis and expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2007; 15(1): 95-98 [DOI: 10.11569/wcjd.v15.i1.95] [Reference Citation Analysis]
8 Robb WB, Mariette C. Predicting the response to chemotherapy in gastric adenocarcinoma: who benefits from neoadjuvant chemotherapy? Recent Results Cancer Res. 2012;196:241-268. [PMID: 23129379 DOI: 10.1007/978-3-642-31629-6_17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
9 Makino H, Uetake H, Danenberg K, Danenberg PV, Sugihara K. Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer. BMC Cancer 2008;8:210. [PMID: 18652704 DOI: 10.1186/1471-2407-8-210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
10 Saif MW, Eloubeidi MA, Russo S, Steg A, Thornton J, Fiveash J, Carpenter M, Blanquicett C, Diasio RB, Johnson MR. Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. J Clin Oncol. 2005;23:8679-8687. [PMID: 16314628 DOI: 10.1200/jco.2005.02.0628] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
11 Shitara K, Sawaki A, Matsuo K, Kondo C, Takahari D, Ura T, Tajika M, Niwa Y, Muro K. A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer. Int J Clin Oncol. 2013;18:539-546. [PMID: 22552360 DOI: 10.1007/s10147-012-0416-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
12 Evans TR, Pentheroudakis G, Paul J, McInnes A, Blackie R, Raby N, Morrison R, Fullarton GM, Soukop M, McDonald AC. A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma. Ann Oncol. 2002;13:1469-1478. [PMID: 12196374 DOI: 10.1093/annonc/mdf243] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
13 Nishina T, Hyodo I, Miyaike J, Inaba T, Suzuki S, Shiratori Y. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'- deoxy-5-fluorouridine. Eur J Cancer. 2004;40:1566-1571. [PMID: 15196541 DOI: 10.1016/j.ejca.2004.02.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
14 Shitara K, Mizota A, Matsuo K, Sato Y, Kondo C, Takahari D, Ura T, Tajika M, Muro K. Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis. Gastric Cancer. 2013;16:48-55. [PMID: 22362376 DOI: 10.1007/s10120-012-0143-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
15 Toi M, Atiqur Rahman M, Bando H, Chow LW. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol. 2005;6:158-166. [PMID: 15737832 DOI: 10.1016/S1470-2045(05)01766-3] [Cited by in Crossref: 106] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
16 Choi IS, Lee HS, Lee KW, Kim H, Kim KH, Kim YJ, Kim JH, Kim WH, Lee JS. Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes. Med Oncol. 2011;28:991-998. [PMID: 20533001 DOI: 10.1007/s12032-010-9590-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
17 Koizumi W, Okayasu I, Hyodo I, Sakamoto J, Kojima H. Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase. Anti-Cancer Drugs 2008;19:819-24. [DOI: 10.1097/cad.0b013e3283094b5d] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
18 Osada S, Osada K, Carr BI. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins 1 1Edited by M. Yaniv. Journal of Molecular Biology 2001;314:765-72. [DOI: 10.1006/jmbi.2001.5171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ichikawa W. Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway. Gastric Cancer. 2006;9:145-155. [PMID: 16952032 DOI: 10.1007/s10120-006-0373-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
20 Terashima M, Fujiwara H, Takagane A, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Oyama K, Takahashi M, Saito K. Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients. European Journal of Cancer 2002;38:2375-81. [DOI: 10.1016/s0959-8049(02)00380-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Yoshinaga K, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Mori M. Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility. Ann Surg Oncol 2003;10:582-7. [PMID: 12794027 DOI: 10.1245/aso.2003.08.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
22 Scartozzi M, Bittoni A, Pistelli M, Galizia E, Berardi R, Giampieri R, Faloppi L, Cascinu S. Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. Cancer Treat Rev 2009;35:451-62. [PMID: 19467788 DOI: 10.1016/j.ctrv.2009.04.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
23 Yang Q, Barbareschi M, Mori I, Mauri F, Muscarà M, Nakamura M, Nakamura Y, Yoshimura G, Sakurai T, Caffo O, Galligioni E, Dalla Palma P, Kakudo K. Prognostic value of thymidine phosphorylase expression in breast carcinoma. Int J Cancer 2002;97:512-7. [PMID: 11802215 DOI: 10.1002/ijc.1633] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
24 Zhao WH, Wang SF, Ding W, Sheng JM, Ma ZM, Teng LS, Wang M, Wu FS, Luo B. Apoptosis induced by preoperative oral 5’-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol 2006; 12(9): 1356-1361 [PMID: 16552801 DOI: 10.3748/wjg.v12.i9.1356] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
25 Terashima M, Fujiwara H, Takagane A, Abe K, Irinoda T, Nakaya T, Yonezawa H, Oyama K, Saito K, Kanzaki N. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer. Gastric Cancer. 2003;6 Suppl 1:71-81. [PMID: 12775024 DOI: 10.1007/s10120-003-0221-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
26 Budman DR. Capecitabine. Invest New Drugs 2000;18:355-63. [PMID: 11081571 DOI: 10.1023/a:1006449315650] [Cited by in Crossref: 26] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]